1. Home
  2. NRSN vs GREE Comparison

NRSN vs GREE Comparison

Compare NRSN & GREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • GREE
  • Stock Information
  • Founded
  • NRSN 2017
  • GREE 1937
  • Country
  • NRSN Israel
  • GREE United States
  • Employees
  • NRSN N/A
  • GREE N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • GREE Investment Bankers/Brokers/Service
  • Sector
  • NRSN Health Care
  • GREE Finance
  • Exchange
  • NRSN Nasdaq
  • GREE Nasdaq
  • Market Cap
  • NRSN 29.8M
  • GREE 31.7M
  • IPO Year
  • NRSN 2021
  • GREE N/A
  • Fundamental
  • Price
  • NRSN $1.18
  • GREE $2.07
  • Analyst Decision
  • NRSN Buy
  • GREE
  • Analyst Count
  • NRSN 2
  • GREE 0
  • Target Price
  • NRSN $14.00
  • GREE N/A
  • AVG Volume (30 Days)
  • NRSN 243.1K
  • GREE 389.0K
  • Earning Date
  • NRSN 11-03-2025
  • GREE 11-07-2025
  • Dividend Yield
  • NRSN N/A
  • GREE N/A
  • EPS Growth
  • NRSN N/A
  • GREE N/A
  • EPS
  • NRSN N/A
  • GREE N/A
  • Revenue
  • NRSN N/A
  • GREE $59,246,000.00
  • Revenue This Year
  • NRSN N/A
  • GREE N/A
  • Revenue Next Year
  • NRSN N/A
  • GREE N/A
  • P/E Ratio
  • NRSN N/A
  • GREE N/A
  • Revenue Growth
  • NRSN N/A
  • GREE N/A
  • 52 Week Low
  • NRSN $0.80
  • GREE $0.58
  • 52 Week High
  • NRSN $2.60
  • GREE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 44.09
  • GREE 55.84
  • Support Level
  • NRSN $1.15
  • GREE $1.83
  • Resistance Level
  • NRSN $1.30
  • GREE $2.23
  • Average True Range (ATR)
  • NRSN 0.07
  • GREE 0.25
  • MACD
  • NRSN -0.00
  • GREE -0.02
  • Stochastic Oscillator
  • NRSN 31.43
  • GREE 53.34

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

Share on Social Networks: